Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs remimazolam for perioperative anxiety and depression in gynecologic laparoscopic surgery
ChiCTR2600117994Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Perioperative anxiety, major depressive disorder (MDD) and postoperative pain comparing R group (remimazolam) with D group (dexmedetomidine) (2 arms). Primary endpoint: Hospital Anxiety and Depression Scale (HADS) scores. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineremimazolam
03
Conditions
Perioperative anxietymajor depressive disorder (MDD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117994.